comparemela.com
Home
Live Updates
J&J: acquisition of Swiss eczema biotech company : comparemela.com
J&J: acquisition of Swiss eczema biotech company
Swiss biotech Numab Therapeutics announced on Tuesday that it had reached an agreement to sell its subsidiary Yellow Jersey Therapeutics to Johnson & Johnson for some $1.25 billion.In a press...
Related Keywords
Zurich ,
Züsz ,
Switzerland ,
Jersey ,
Swiss ,
,
Johnson ,
Numab Therapeutics ,
Yellow Jersey Therapeutics ,
comparemela.com © 2020. All Rights Reserved.